Patents Assigned to ALEYEGN TECHNOLOGIES LLC
-
Patent number: 11957621Abstract: An iridocorneal angle of the eye can be opened with a plurality of treatment locations at least about 2 mm radially outward from a limbus of the eye. The opening on the angle can be beneficial for treating both narrow angle glaucoma and open angle glaucoma. The plurality of treatment locations located away from the limbus can decrease invasiveness and complexity of the procedure. The plurality of treatment locations at least about 2 mm away from the limbus can provide tensioning to zonules coupled to the lens of the eye to flatten the lens of the eye, which can allow the iris to move posteriorly so as to open the iridocorneal angle. The plurality of treatment locations may comprise scleral locations, in which shrinkage of scleral tissue at the plurality of treatment locations provides tensioning to the zonules.Type: GrantFiled: September 21, 2018Date of Patent: April 16, 2024Assignee: ALeyeGN Technologies LLCInventors: Rajeev Herekar, Satish V. Herekar, John Randall Samples
-
Publication number: 20240000610Abstract: An ab externo automated laser treatment system for treating an eye in a subject, includes a non-contact laser source configured to generate a laser beam having at least one wavelength to treat the eye by directing the laser beam from a location spaced from the eye, wherein the at least one wavelength is a near-infrared wavelength in the range of about 0.5-2.Type: ApplicationFiled: September 18, 2023Publication date: January 4, 2024Applicant: ALEYEGN TECHNOLOGIES LLCInventors: Giorgio Dorin, John Randall Samples, Michael K. Ballard, Satish Herekar, William Eddington, Perry Binder
-
Patent number: 11759358Abstract: An ab externo automated laser treatment system for treating an eye in a subject, includes a non-contact laser source configured to generate a laser beam having at least one wavelength to treat the eye by directing the laser beam from a location spaced from the eye, wherein the at least one wavelength is a near-infrared wavelength in the range of about 0.5-2.Type: GrantFiled: November 4, 2019Date of Patent: September 19, 2023Assignee: ALeyeGN Technologies LLCInventors: Giorgio Dorin, John Randall Samples, Michael K. Ballard, Satish Herekar, William Eddington, Perry Binder
-
Publication number: 20220395398Abstract: A laser delivery system is configured to delivery light energy to soften and realign the tissue of the eye in order to increase accommodation and treat glaucoma. The laser system can be configured to increase a circumlental space of the eye and increase movement of a posterior vitreous zonule in order to increase accommodation. The light energy may comprise wavelengths strongly absorbed by collagen of the sclera. In many embodiments a heat sink is provided to couple to the conjunctiva and the heat sink comprises a material transmissive to the light energy absorbed by collagen, for example Zinc Selenide. The heat sink can be chilled to inhibit damage to the conjunctiva of the eye. In many embodiments, one or more layers of the epithelium of the eye remain substantially intact above the zone where the eye has been treated when the heat sink has been removed.Type: ApplicationFiled: April 27, 2022Publication date: December 15, 2022Applicant: ALeyeGN Technologies LLCInventors: Satish HEREKAR, Rajeev HEREKAR
-
Patent number: 11369516Abstract: A laser delivery system is configured to delivery light energy to soften and realign the tissue of the eye in order to increase accommodation and treat glaucoma. The laser system can be configured to increase a circumlental space of the eye and increase movement of a posterior vitreous zonule in order to increase accommodation. The light energy may comprise wavelengths strongly absorbed by collagen of the sclera. In many embodiments a heat sink is provided to couple to the conjunctiva and the heat sink comprises a material transmissive to the light energy absorbed by collagen, for example Zinc Selenide. The heat sink can be chilled to inhibit damage to the conjunctiva of the eye. In many embodiments, one or more layers of the epithelium of the eye remain substantially intact above the zone where the eye has been treated when the heat sink has been removed.Type: GrantFiled: August 26, 2019Date of Patent: June 28, 2022Assignee: ALeyeGN Technologies LLCInventors: Satish Herekar, Rajeev Herekar
-
Patent number: 11259963Abstract: A method is provided for treating a targeted area of ocular tissue in a tissue-sparing manner comprising use of two or more therapeutic modalities, including thermal radiation source (such as an CW infrared fiber laser), operative in a wavelength range that has a high absorption in water, and photochemical collagen cross-linking (CXL), together with one or more specific system improvements, such as pen-operative feedback measurements for tailoring of the therapeutic modalities, an ocular tissue surface thermal control/cooling mechanism and a source of deuterated water/riboflavin solution in a delivery system targeting ocular tissue in the presence of the ultraviolet radiation. Additional methods of rapid cross-linking (RXL), are provided that enables cross-linking (CXL) therapy to be combined with thermal therapy.Type: GrantFiled: March 21, 2019Date of Patent: March 1, 2022Assignee: ALeyeGN Technologies LLCInventors: Satish V. Herekar, Edward E. Manche, Donald J. Eaton
-
Publication number: 20220031503Abstract: An ab externo automated laser treatment system for treating an eye in a subject, includes a non-contact laser source configured to generate a laser beam having at least one wavelength to treat the eye by directing the laser beam from a location spaced from the eye, wherein the at least one wavelength is a near-infrared wavelength in the range of about 0.5-2.Type: ApplicationFiled: November 4, 2019Publication date: February 3, 2022Applicant: ALEYEGN TECHNOLOGIES LLCInventors: Giorgio Dorin, John Randall Samples, Michael K. Ballard, Satish Herekar, William Eddington, Perry Binder
-
Publication number: 20210052416Abstract: Methods, systems, and apparatus to treat glaucoma of the eye are disclosed. They apply energy to the tissue adjacent collector channels and/or Schlemm's Canal. Applying energy to the surface of the eye, such as the sclera, adjacent the collector channels and/or their ostia can dilate the collector channels and/or their ostia to improve uveoscleral outflow to reduce intraocular pressure. In some examples energy is applied to the eye with a laser at a sufficient energy to shrink the tissue on opposing sides of the collector channels to induce channel dilation.Type: ApplicationFiled: March 8, 2019Publication date: February 25, 2021Applicant: ALeyeGN Technologies LLCInventors: Satish V. Herekar, John Randall Samples
-
Publication number: 20200306080Abstract: An iridocorneal angle of the eye can be opened with a plurality of treatment locations at least about 2 mm radially outward from a limbus of the eye. The opening on the angle can be beneficial for treating both narrow angle glaucoma and open angle glaucoma. The plurality of treatment locations located away from the limbus can decrease invasiveness and complexity of the procedure. The plurality of treatment locations at least about 2 mm away from the limbus can provide tensioning to zonules coupled to the lens of the eye to flatten the lens of the eye, which can allow the iris to move posteriorly so as to open the iridocorneal angle. The plurality of treatment locations may comprise scleral locations, in which shrinkage of scleral tissue at the plurality of treatment locations provides tensioning to the zonules.Type: ApplicationFiled: September 21, 2018Publication date: October 1, 2020Applicant: ALeyeGN Technologies LLCInventors: Rajeev Herekar, Satish V. Herekar, John Randall Samples
-
Publication number: 20200000638Abstract: A method is provided for treating a targeted area of ocular tissue in a tissue-sparing manner comprising use of two or more therapeutic modalities, including thermal radiation source (such as an CW infrared fiber laser), operative in a wavelength range that has a high absorption in water, and photochemical collagen cross-linking (CXL), together with one or more specific system improvements, such as pen-operative feedback measurements for tailoring of the therapeutic modalities, an ocular tissue surface thermal control/cooling mechanism and a source of deuterated water/riboflavin solution in a delivery system targeting ocular tissue in the presence of the ultraviolet radiation. Additional methods of rapid cross-linking (RXL), are provided that enables cross-linking (CXL) therapy to be combined with thermal therapy.Type: ApplicationFiled: March 21, 2019Publication date: January 2, 2020Applicant: ALeyeGN Technologies LLCInventors: Satish V. HEREKAR, Edward E. MANCHE, Donald J. EATON
-
Publication number: 20200000634Abstract: A laser delivery system is configured to delivery light energy to soften and realign the tissue of the eye in order to increase accommodation and treat glaucoma. The laser system can be configured to increase a circumlental space of the eye and increase movement of a posterior vitreous zonule in order to increase accommodation. The light energy may comprise wavelengths strongly absorbed by collagen of the sclera. In many embodiments a heat sink is provided to couple to the conjunctiva and the heat sink comprises a material transmissive to the light energy absorbed by collagen, for example Zinc Selenide. The heat sink can be chilled to inhibit damage to the conjunctiva of the eye. In many embodiments, one or more layers of the epithelium of the eye remain substantially intact above the zone where the eye has been treated when the heat sink has been removed.Type: ApplicationFiled: August 26, 2019Publication date: January 2, 2020Applicant: ALeyeGN Technologies LLCInventors: Satish HEREKAR, Rajeev HEREKAR
-
Publication number: 20190099291Abstract: The methods and apparatus disclosed herein can be used to adjust the effective lens position (“ELP”) of the eye in order to correct refractive error of the eye. The methods and apparatus can be configured to apply energy to the sclera and other regions of the eye in order to adjust the effective lens position of the eye for far vision. The sclera can be treated in order to shrink or relax the sclera, and combinations thereof in order to adjust the position of the lens of the eye in order to correct vision related to refractive error of the eye. A target location of the lens can be determined to correct the refractive error of the eye, and the energy applied in order to move the lens toward the target location.Type: ApplicationFiled: September 18, 2018Publication date: April 4, 2019Applicant: ALEYEGN TECHNOLOGIES LLCInventors: Rajeev HEREKAR, Satish V. HEREKAR